Products for Research Use Only

Idelalisib-d5

CAT: 0804-HY-13026SSize: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-13026SSize:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Idelalisib-d5 is a deuterium labeled Idelalisib. Idelalisib is a highly selective and orally bioavailable p110δ inhibitor[1].
CAS Number
1830330-31-8
Product Name Alternative
CAL-101 D5; GS-1101 D5
UNSPSC
12352005
Target
Autophagy; PI3K
Type
Isotope-Labeled Compounds
Related Pathways
Autophagy; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
98.35
Solubility
10 mM in DMSO|DMF : ≥ 30mg/mL|DMSO : ≥ 25mg/mL|Ethanol : ≥ 15mg/mL
Smiles
O=C1N(C2=C([2H])C([2H])=C([2H])C([2H])=C2[2H])C([C@@H](NC3=C4N=CNC4=NC=N3)CC)=NC5=C1C(F)=CC=C5
Molecular Formula
C22H13D5FN7O
Molecular Weight
420.45
References & Citations
[1]Lannutti BJ, et al. CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood, 2011, 117 (2), 591-594.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Popular Products